Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

NeurogesX Presents Positive Data From Trial Of Pain Patch

Nov. 1, 2011

No Abstract

NewCo News: Aileron Raises $7M For Work On Peptide Technology Platform

Nov. 1, 2011

No Abstract

KineMed Applying Translation Technologies In Deal With Bayer

Nov. 1, 2011

No Abstract

Renovis Cuts Staff As Focus Moves To Preclinical Programs

Nov. 1, 2011

No Abstract

Santhera Starts Phase III Trial In Friedreich's Ataxia Patients

Oct. 1, 2007

Santhera Starts Phase III Trial In Friedreich's Ataxia Patients

Oct. 1, 2007

NPS, Nycomed Enter Potential $185M Deal Covering Gattex

Sep. 27, 2007

NPS, Nycomed Enter Potential $185M Deal Covering Gattex

Sep. 27, 2007

Sonus Crashes On Failed Pivotal Trial Of Tocosol Paclitaxel Drug

Sep. 25, 2007

Sonus Crashes On Failed Pivotal Trial Of Tocosol Paclitaxel Drug

Sep. 25, 2007

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 10, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.